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Abstract
The conversion of lineage-committed cells to induced pluripotent stem cells (iPSCs) by
reprogramming is accompanied by a global remodeling of the epigenome1-5, resulting in altered
patterns of gene expression2,6-9. Here we characterize the transcriptional reorganization of large
intergenic non-coding RNAs (lincRNAs)10,11 that occurs upon derivation of human iPSCs, and
identify numerous lincRNAs whose expression is linked to pluripotency. Among these, we
defined 10 lincRNAs whose expression was elevated in iPSCs compared with embryonic stem
cells (ESCs), suggesting that their activation may promote the emergence of iPSCs. Supporting
this, our results indicate that these lincRNAs are direct targets of key pluripotency transcription
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factors. Using loss- and gain-of-function approaches, we found that one such lincRNA (lincRNA-
RoR) modulates reprogramming, thus providing a first demonstration for critical functions of
lincRNAs in the derivation of pluripotent stem cells.
Cellular reprogramming demonstrates the remarkable plasticity of cell fates, illustrated by
the isolation of induced pluripotent stem cells (iPSCs) from fibroblasts6-9. Molecular
analysis of epigenetic modifications has revealed a near complete remodeling of the
epigenome during reprogramming1-4,12, resulting in the conversion of lineage-specific to
uniform protein-coding and miRNA gene expression profiles similar to embryonic stem
cells (ESCs)2,6-9. We and others have recently discovered a novel class of large intergenic
non-coding RNAs (lincRNAs) that are expressed in a cell type-specific manner13 and can
associate with epigenetic regulators11,14-16 involved in pluripotency and lineage
commitment17,18.
To date, it is not known whether large-scale transcriptional changes induced by
reprogramming apply to lincRNAs, and if these changes have any functional relevance. To
test this, we compared the transcriptional profiles of human lincRNAs alongside protein-
coding genes across fibroblasts, their derivative iPSCs, and ESCs. We reprogrammed four
primary fibroblast lines7 and validated the functionality of resulting iPSC lines
(Supplementary Figure 1, 2, and data not shown). We then performed DNA microarray
analysis of the parental fibroblasts, seven of their derivative iPSC lines, and two ESC lines.
Consistent with previous studies, analysis of gene expression profiles revealed that all iPSCs
were similar to ESCs19,20, and distinct from fibroblasts (Figure 1A, Supplementary Figure
3). We detected 3694 and 3283 genes up- and downregulated, respectively, in iPSCs and
ESCs compared with fibroblasts (>2fold, P<0.05; Figure 1B). Taken together, our
fibroblast-derived iPSCs fulfill functional criteria of bona fide iPSCs20 and exhibit a
uniform protein-coding gene expression profile similar to ESCs.
To explore the expression of lincRNAs, we designed a microarray probing ~900 lincRNAs
in the human genome11 and analyzed their expression in the above cell lines. The global
lincRNA expression profiles of iPSCs were very similar to ESCs and distinct from
fibroblasts (Figure 1C). We observed 133 and 104 lincRNAs that were induced or repressed
(>2fold, FWER<0.05) across all iPSCs and ESCs compared with fibroblasts (Figure 1D, E,
Supplementary Table 1). Similar to protein-coding genes, direct reprogramming resulted in
concomitant activation or repression of numerous lincRNAs consistent with a reactivation of
the ESC state.
To exclude the possibility that reprogramming-induced changes in lincRNA expression
reflects the opening and closing of chromatin domains of neighboring protein-coding genes,
we analyzed the correlation of expression between each reprogrammed lincRNA and their
neighboring genes, and found no significant correlation (P=0.999, Figure 1F). This indicates
an independent and cell type-specific regulation of lincRNA expression.
We sought to identify lincRNAs with potentially important functions in ESCs/iPSCs.
Among the many pluripotency-associated lincRNAs (Figure 1D and Supplementary Figure
4), we searched for those that were expressed in both ESCs and iPSCs, but showed elevated
levels in iPSCs relative to ESCs, reasoning that their high expression may have conferred a
selective advantage on emerging iPSCs. We identified 28 lincRNAs that showed greater
expression in fibroblast-iPSCs relative to ESCs (>2fold, FWER<0.05; Figure 2A), and refer
to these as “iPSC-enriched” lincRNAs hereafter.
We hypothesized that if iPSC-enriched lincRNAs are important for reprogramming, they
should be elevated in iPSCs independent of the cell-of-origin. To test this, we profiled
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lincRNA expression in CD34+ hematopoietic stem/progenitor cells, two CD34+-iPSC
lines21 and ESCs, using the same approach as above. Like fibroblast-iPSCs, CD34+-iPSCs
had similar global lincRNA expression profiles as ESCs, distinct from that of CD34+ cells
(Supplementary Figure 4). 10 of the 28 lincRNAs elevated in fibroblast-iPSCs were also
elevated in CD34+-iPSCs (Figure 2B, Supplementary Figure 5). This overlap was
statistically significant (P<0.0001). We independently validated levels of 8/10 common
iPSC-enriched lincRNAs by qRT-PCR (Figure 2B), and detected considerable variation in
expression. Positive selection for minimal RNA levels and the absence of counter-selection
against higher expression during reprogramming may be the cause for this variability.
Collectively, these results demonstrate that numerous lincRNAs are tightly associated with
the pluripotent state, including a subset that is consistently enriched in iPSCs independent of
the cell-of-origin.
If iPSC-enriched lincRNAs are important for iPSC derivation, we suspected a link with the
pluripotency network. To test this, we first intersected published OCT4 binding regions in
ESCs22 with iPSC-enriched lincRNA loci (demarcated by domains of histone H3K4 and
H3K36 methylation10,11, named according to their neighboring 3’ gene), and identified three
overlapping loci: lincRNA-SFMBT2, lincRNA-VLDLR, and lincRNA-ST8SIA3. We
performed independent ChIP-qPCR to validate the binding of OCT4, and probe for SOX2
and NANOG occupancy at these sites. All three transcription factors occupied these regions,
coinciding with or in close proximity to lincRNA promoters (peaks of H3K4me10; Figure
3A, Supplementary Figure 6).
To determine whether expression of iPSC-enriched lincRNAs is dependent on pluripotency
transcription factors, we depleted OCT4 in iPSCs and ESCs using siRNAs and monitored
the levels of iPSC-enriched lincRNAs. We verified OCT4 knock-down and induction of the
differentiation marker LMNA (Figure 3B, Supplementary Figure 7). Levels of all three
iPSC-enriched lincRNAs fell within 72h (Figure 3B, Supplementary Figure 7C). To further
verify that downregulation of iPSC-enriched lincRNAs is caused by perturbation of the
pluripotency network, we induced embryoid body (EB) formation as a distinct pathway of
differentiation. Again, levels of all three iPSC-enriched lincRNAs fell within two days
(Figure 3C, Supplementary Figure 7D). The expression of these lincRNAs thus appears
controlled by pluripotency transcription factors in ESCs and iPSCs.
We turned to investigate the functional roles of iPSC-enriched lincRNAs in the
reprogramming process. To this end, we generated shRNA-expressing lentiviruses targeting
lincRNA-ST8SIA3 and lincRNA-SFMBT2, which showed the strongest response to EB
differentiation and OCT4 knock-down, and validated each knock-down relative to a non-
targeting control shRNA (Figure 4A, Supplementary Figure 8A). To test the effect of
lincRNA depletion on reprogramming, we infected dH1f fibroblasts7 with both the shRNA-
expressing and the reprogramming viruses7,9, and scored emerging iPSC colonies based on
Tra-1-60 marker expression (day 21)20. Interference with lincRNA-SFMBT2 did not affect
iPSC colony formation (Supplementary Figure 8B, C), suggesting that lincRNA-SFMBT2 is
not essential, or alternatively, that its moderate reduction was insufficient to perturb
reprogramming. In contrast, knock-down of lincRNA-ST8SIA3 resulted in a significant 2 to
8-fold decrease of iPSC colonies relative to the control, where as progenitor cells were
unaffected (P<0.01; Figure 4B, C, D, Supplementary Table 2). As expected, resulting iPSC
colonies fulfilled additional criteria of fully reprogrammed cells (Supplementary Figure 9).
These results demonstrate a functional requirement of lincRNA-ST8SIA3 expression for
iPSC derivation.
Several studies have established critical roles of cell proliferation and bypass of senescence
during the early stages of reprogramming23-27. We therefore examined if knockdown of
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lincRNA-ST8SIA3 compromised cell growth of fibroblasts or cells during this window, and
failed to detect significant differences in cells infected with the lincRNA-ST8SIA3-targeting
virus compared with the control (Figure 4C, Supplementary Figure 10). In addition, the
kinetics of reprogramming upon knock-down of lincRNA-ST8SIA3 was similar to the
control (Supplementary Figure 11). Collectively, these findings point to a specific inhibition
of the reprogramming process, rather than a delay of iPSC formation upon loss of lincRNA-
ST8SIA3.
Intrigued by this phenotype, we used 5’ and 3’ rapid amplification of cDNA ends to clone
the full-length transcript of lincRNA-ST8SIA3 (Figure 4E), which recovered a 2.6kb long
RNA comprised of four exons (Figure 4E, red). We did not detect any clones that were
spliced to protein-coding genes nor intact open reading frames, and confirmed the presence
of a single transcript of expected length by Northern Blotting (Figure 4E, Supplementary
Figure 12).
We next used a complementary gain-of-function approach to test whether elevated
lincRNA-ST8SIA3 expression might enhance reprogramming. We infected dH1fs with
empty pBabe-puro retrovirus, GFP-expressing, or lincRNA-ST8SIA3-expressing virus,
selected transgenic cells, and documented 25 to 70-fold overexpression of lincRNA-
ST8SIA3 relative to the levels in H9 ESCs (Figure 4F). We induced reprogramming in these
stable cell lines and consistently observed a more than 2-fold increase in iPSC colony
formation (day 28 +/-2 days) (P<0.001; Figure 4G). This was not associated with significant
changes in cell growth of fibroblasts or cells at early stages of reprogramming (Figure 4H,
Supplementary Figure 10). Thus, overexpression of lincRNA-ST8SIA3 positively affects the
establishment of iPSCs during reprogramming (Figure 4G, I), in addition to possible
functions in iPSC maintenance. Supporting the latter, transient knock-down of lincRNA-
ST8SIA3 in ESCs and established iPSCs resulted in a growth deficiency linked with
elevated apoptosis (Supplementary Figure 13).
To gain insight into which cellular pathways are affected by lincRNA-ST8SIA3 knock-
down, we performed microarray gene expression analysis. Consistent with its apoptotic
phenotype, knock-down of lincRNA-ST8SIA3 led to upregulation of genes involved in the
p53 response, the response to oxidative stress and DNA damage-inducing agents, as well as
cell death pathways (Supplementary Table 3). Interestingly, simultaneous knock-down of
p53 partially rescued the apoptotic phenotype caused by ablation of lincRNA-ST8SIA3
(Supplementary Figure 14). Taken together, these results suggest that lincRNA-ST8SIA3
plays a role in promoting survival in iPSCs and ESCs, likely by preventing the activation of
cellular stress pathways including the p53 response.
Our transcriptional profiling approach has revealed numerous lincRNAs that are part of the
transcriptional repertoire of human ESCs and are induced during reprogramming of different
cell types. We have identified several iPSC-enriched lincRNAs that appear to be directly
regulated by the pluripotency network. Interestingly, we found no direct syntenic correlates
of the 10 iPSC-enriched lincRNAs expressed in mouse ESCs (with the exception of
lincRNA-VLDLR). Similar to what has been described for protein-coding genes28, the
transcriptional networks of lincRNAs in ESCs may have become rewired, conferring
species-specific regulation.
The modulation of reprogramming by lincRNA-ST8SIA3 provides the first functional
example of a lincRNA in establishing iPSCs, we therefore name it lincRNA-RoR for
Regulator of Reprogramming. Future studies will be required to decipher the molecular
mechanism by which lincRNA-RoR acts, and to gain a global understanding of lincRNA
function in the establishment and maintenance of pluripotency. One possibility is that
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pluripotency-associated lincRNAs interface with chromatin modifying complexes to assist
in the regulation of the distinct epigenetic architecture in pluripotent cells. Supporting this,
previous studies have demonstrated critical roles for chromatin-modifying complexes in the
establishment and maintenance of pluripotency, and numerous lincRNAs can interact with
these complexes to impart target specificity11,15,16. Here we demonstrate the modulation of
reprogramming by a large non-coding RNA, supporting the notion that lincRNAs represent
an additional layer of complexity in the networks controlling cellular identity.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We thank Hongguang Huo, Alexander DeVine for technical assistance; Sutheera Ratanasirintrawoot and Erin
McLoughlin for reagents; Mathew W. Lensch for teratoma interpretation,. J.L.R. is a Damon Runyon-Rachleff,
Searle, Smith Family Foundation and Richard Merkin Foundation Scholar. S.L. was supported by a Human Frontier
Science Program Organization long-term fellowship. Y.-H.L. is supported by the Agency of Science, Technology
and Research International Fellowship and the A*Star Institute of Medical Biology, Singapore. GQD is an
investigator of the Howard Hughes Medical Institute. Research was funded by grants from the National Institutes of
Health (NIH) to G.Q.D (1 RC2-HL102815) and J.L.R. (1DP2OD00667-01).
References
1. Ball MP, et al. Targeted and genome-scale strategies reveal gene-body methylation signatures in
human cells. Nat Biotechnol 2009;27:361–8. [PubMed: 19329998]
2. Chin MH, et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene
expression signatures. Cell Stem Cell 2009;5:111–23. [PubMed: 19570518]
3. Doi A, et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes
human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet
2009;41:1350–3. [PubMed: 19881528]
4. Maherali N, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and
widespread tissue contribution. Cell Stem Cell 2007;1:55–70. [PubMed: 18371336]
5. Mikkelsen TS, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed
cells. Nature 2007;448:553–60. [PubMed: 17603471]
6. Lowry WE, et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc
Natl Acad Sci U S A 2008;105:2883–8. [PubMed: 18287077]
7. Park IH, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature
2008;451:141–6. [PubMed: 18157115]
8. Takahashi K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined
factors. Cell 2007;131:861–72. [PubMed: 18035408]
9. Yu J, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science
2007;318:1917–20. [PubMed: 18029452]
10. Guttman M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding
RNAs in mammals. Nature 2009;458:223–7. [PubMed: 19182780]
11. Khalil AM, et al. Many human large intergenic noncoding RNAs associate with chromatin-
modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 2009;106:11667–72.
[PubMed: 19571010]
12. Mikkelsen TS, et al. Dissecting direct reprogramming through integrative genomic analysis. Nature
2008;454:49–55. [PubMed: 18509334]
13. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell
2009;136:629–41. [PubMed: 19239885]
14. Nagano T, et al. The Air noncoding RNA epigenetically silences transcription by targeting G9a to
chromatin. Science 2008;322:1717–20. [PubMed: 18988810]
Loewer et al. Page 5
Nat Genet. Author manuscript; available in PMC 2011 February 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
15. Rinn JL, et al. Functional demarcation of active and silent chromatin domains in human HOX loci
by noncoding RNAs. Cell 2007;129:1311–23. [PubMed: 17604720]
16. Zhao J, Sun BK, Erwin JA, Song JJ, Lee JT. Polycomb proteins targeted by a short repeat RNA to
the mouse X chromosome. Science 2008;322:750–6. [PubMed: 18974356]
17. Boyer LA, et al. Polycomb complexes repress developmental regulators in murine embryonic stem
cells. Nature 2006;441:349–53. [PubMed: 16625203]
18. Lee TI, et al. Control of developmental regulators by Polycomb in human embryonic stem cells.
Cell 2006;125:301–13. [PubMed: 16630818]
19. Assou S, et al. A meta-analysis of human embryonic stem cells transcriptome integrated into a
web-based expression atlas. Stem Cells 2007;25:961–73. [PubMed: 17204602]
20. Chan EM, et al. Live cell imaging distinguishes bona fide human iPS cells from partially
reprogrammed cells. Nat Biotechnol 2009;27:1033–7. [PubMed: 19826408]
21. Loh YH, et al. Generation of induced pluripotent stem cells from human blood. Blood
2009;113:5476–9. [PubMed: 19299331]
22. Marson A, et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of
embryonic stem cells. Cell 2008;134:521–33. [PubMed: 18692474]
23. Hong H, et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.
Nature. 2009
24. Kawamura T, et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming.
Nature. 2009
25. Li H, et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature. 2009
26. Marion RM, et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell
genomic integrity. Nature. 2009
27. Utikal J, et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS
cells. Nature. 2009
28. Kunarso G, et al. Transposable elements have rewired the core regulatory network of human
embryonic stem cells. Nat Genet 2010;42:631–4. [PubMed: 20526341]
29. Dinger ME, et al. Long noncoding RNAs in mouse embryonic stem cell pluripotency and
differentiation. Genome Res 2008;18:1433–45. [PubMed: 18562676]
30. Reich M, et al. GenePattern 2.0. Nat Genet 2006;38:500–1. [PubMed: 16642009]
31. Loh YH, et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse
embryonic stem cells. Nat Genet 2006;38:431–40. [PubMed: 16518401]
Loewer et al. Page 6
Nat Genet. Author manuscript; available in PMC 2011 February 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1.
Direct reprogramming of fibroblasts converts both protein-coding gene and lincRNA
expression to a puripotent cell-specific profile. A, C) Unsupervised hierarchical clustering of
protein-coding gene expression (A) and lincRNA expression (C) segregates fibroblasts (red)
from ESCs and fibroblast-derived iPSCs (blue). B, D) Supervised hierarchical clustering
analysis identifies 6865 protein-coding genes (B) and 237 lincRNAs (D) that are
differentially expressed between ESCs/iPSCs and fibroblasts (genes: >2fold, P<0.05;
lincRNAs: >2fold, FWER<0.05). Expression values are represented in shades of red and
blue relative to being above (red) or below (blue) the median expression value across all
samples (log scale 2, from -3 to +3). hFib2 fibroblasts are represented as two replicates
(hFib2 and hFib2a). E) Examples of reprogrammed lincRNAs; left: lincRNA expressed in
all fibroblasts is repressed in all pluripotent cells, right: a pluripotent cell-specific lincRNA
that becomes activated during reprogramming. Expression values for each tiled probe (x-
axis) are displayed as normalized hybridization intensity (y-axis). F) Correlation analysis of
lincRNAs and neighboring genes. Density plot of multiple testing corrected p-values (x-
axis) for lincRNAs that are positively (blue) or negatively (red) correlated with their protein-
coding gene neighbors.
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Figure 2.
Several lincRNAs show enriched expression in iPSCs compared with ESCs. A) Heatmap of
28 and 52 lincRNAs that are more highly expressed in fibroblast-derived iPSCs (left) and
CD34+-derived iPSCs (right), respectively, compared with ESCs (>2fold, FWER<0.05).
Expression values are represented in shades of red and blue relative to being above (red) or
below (blue) the median expression value across all samples (log scale 2, from -3 to +3). B)
Top: Venn Diagram shows 10 lincRNAs that are commonly enriched in fibroblast- and
CD34+-derived iPSCs. Bottom: qRT-PCR validation of the 10 commonly enriched
lincRNAs (named according to their 3’ protein-coding gene neighbor) across three human
ESC lines (H1, H9, BG01), fibroblasts (MRC5, MSC, hFib2) and CD34+ cells, and their
derivative iPSC lines. Expression values are represented relative to the RNA levels in H9
ESCs.
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Figure 3.
Transcriptional regulation of iPSC-enriched lincRNAs. A) iPSC-enriched lincRNA loci are
bound by pluripotency transcription factors. Top: lincRNA loci demarcated by domains
enriched in histone H3K4me3 indicating RNA polymerase II promoters and H3K36me3
indicating regions of transcriptional elongation10,29 in human ESCs (green and blue,
respectively). Bottom: ChIP in hFib2-iPS5 cells followed by quantitative PCR analysis
detects binding of OCT4, SOX2, and NANOG within lincRNA-SFMBT2, lincRNA-
VLDLR, and lincRNA-ST8SIA3 regions close to lincRNA promoter regions (peaks of
H3K4me). ChIP enrichment values are displayed normalized to a control region (chr12:
7,839,777- 7,839,966; hg18); anti-GFP ChIP was used as a negative control. Positions of
ChIP-PCR fragments are indicated by black lines. B) Changes in iPSC-enriched lincRNA
levels upon siRNA-mediated knock-down of OCT4 in iPSC. Top: qRT-PCR of OCT4,
NANOG and LMNA transcript levels upon depletion of OCT4. Bottom: qRT-PCR of iPSC-
enriched lincRNA levels upon depletion of OCT4. Transcript levels are displayed relative to
non-targeting control siRNAs (ctrl siRNA) (n=3, error bars +/-s.e.m). C) iPSC-enriched
lincRNA expression during EB differentiation. Top: qRT-PCR analysis monitoring
transcript levels of pluripotency markers (OCT4 and NANOG) and the differentiation marker
LMNA over a ten day differentiation time-course; bottom: qRT-PCR analysis of iPSC-
enriched lincRNAs. RNA levels are depicted relative to undifferentiated cells on day 0 (n=3,
error bars +/-s.e.m).
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Figure 4.
LincRNA-ST8SIA3 expression modulates reprogramming. A) qRT-PCR verifies lincRNA-
ST8SIA3 knock-down with Linc-sh1 and Linc-sh2 in hFib2-iPS5 cells relative to a non-
targeting shRNA control (n=2, error bar: +/-s.e.m). B) Quantification of Tra-1-60+ iPSC
colonies upon knock-down of lincRNA-ST8SIA3 relative to the control (day 21; n=4, error
bar: +/-s.e.m). C) Quantification of cell numbers on day 6-7 of reprogramming in lincRNA-
ST8SIA3 shRNA samples relative to the control (n=4, error bar: +/-s.e.m). D) Images
showing quarters of Tra-1-60 stained reprogramming plates upon infection of a non-
targeting control and two lincRNA-ST8SIA3 targeting shRNAs. Arrowheads mark
Tra-1-60+ iPSC colonies. E) Structure of the lincRNA-ST8SIA3 locus. Green, Blue:
Demarcation of the H3K4me-H3K36me domain in ESCs. Red: Structure of lincRNA-
ST8SIA3 RNA; asterisk marks position of OCT4/SOX2/NANOG binding (see Figure 3A).
Right: Northern hybridization of lincRNA-ST8SIA3 detects a 2.6kb transcript in hFib2-
iSP5, but not dH1f (full-length blot see Supplementary Figure 12). F) qRT-PCR verifies
lincRNA-ST8SIA3 overexpression from a retroviral vector (pBabe-lincRNA-ST8SIA3)
compared with pBabe-puro and pBabe-puro-GFP vectors in dH1f relative to the levels in H9
ESCs and hFib2-iPS5 (n=2, error bars: +/-s.e.m). G) Quantification of Tra-1-60+ iPSC
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colonies upon overexpression of lincRNA-ST8SIA3 compared to pBabe and pBabe-GFP
controls (n=5, error bar: +/-s.e.m.). H) Quantification of cell numbers on day 6-7 in
lincRNA-ST8SIA3 overexpressing cells and controls. Cell numbers are relative to the pBabe
control (day 28 +/-2; n=5, error bar: +/- s.e.m.). I) Image of quarter-plates of Tra-1-60
stained colonies (arrowheads) in pBabe, pBabe-GFP, and pBabe-lincRNA-ST8SIA3
infected samples. Statistical analysis was performed using Student’s t-test.
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